A 17-Estradiol-Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women: A Randomized Controlled Trial

被引：0

作者：

不详

机构：

[1] Columbia University Medical Center, New York

[2] Clinical Research Center, Eastern Virginia Medical School, Norfolk

[3] University of California, San Francisco

[4] Sutter East Bay Medical Foundation, Berkeley

[5] University of Florida College of Medicine-Jacksonville, Jacksonville

[6] EndoRheum Consultants, LLC, Malvern

[7] and TherapeuticsMD, Boca Raton

来源：

OBSTETRICAL & GYNECOLOGICAL SURVEY | 2018年 / 73卷 / 11期

关键词：

D O I：

10.1097/01.ogx.0000549834.30469.f2

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

(Abstracted from Obstet Gynecol 2018;132:161-170) After the first publication of Women's Health Initiative findings in 2002, many women stopped taking US Food and Drug Administration (FDA)-approved, hormone therapy (HT) and started using non-FDA-approved, natural compounded HT believing that it was a safer option. In 2015, it was estimated that 1 million to 2.5 million US women used the unapproved, compounded HT.

引用

页码：630 / 632

页数：3

共 50 条

[1] A 17β-Estradiol-Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women
Lobo, Rogerio A.
Archer, David F.
Kagan, Risa
Kaunitz, Andrew M.
Constantine, Ginger D.
Pickar, James H.
Graham, Shelli
Bernick, Brian
Mirkin, Sebastian
[J]. OBSTETRICS AND GYNECOLOGY, 2018, 132 (01): : 161 - 170
[2] A 17β-Estradiol-Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women: A Randomized Controlled Trial (vol 132, pg 161, 2018)
Lobo, R. A.
Archer, D. F.
Kagan, R.
Kaunitz, A. M.
Constantine, G. D.
Pickar, J. H.
[J]. OBSTETRICS AND GYNECOLOGY, 2018, 132 (03): : 786 - 787
[3] Oral micronized progesterone for vasomotor symptoms-a placebo-controlled randomized trial in healthy postmenopausal women
Hitchcock, Christine L.
Prior, Jerilynn C.
[J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2012, 19 (08): : 886 - 893
[4] Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms
Simon, James A.
Kaunitz, Andrew M.
Kroll, Robin
Graham, Shelli
Bernick, Brian
Mirkin, Sebastian
[J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2019, 26 (05): : 506 - 512
[5] Effects of applied relaxation on vasomotor symptoms in postmenopausal women: a randomized controlled trial
Lindh-Astrand, Lotta
Nedstrand, Elizabeth
[J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (04): : 401 - 408
[6] Percutaneous 17β-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women
Archer, DF
[J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (06): : 516 - 521
[7] A combined, bioidentical, oral, 17β-estradiol and progesterone capsule for the treatment of moderate to severe vasomotor symptoms due to menopause
Archer, David F.
Bernick, Brian A.
Mirkin, Sebastian
[J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (08) : 729 - 739
[8] Breast effects of oral, combined 17β-estradiol, and progesterone capsules in menopausal women: a randomized controlled trial
Mejia-Gomez, Javier
Gronwald, Jacek
Senter, Leigha
Karlan, Beth Y.
Tung, Nadine
Wolfman, Wendy
Demsky, Rochelle
Sun, Ping
Narod, Steven A.
Kotsopoulos, Joanne
[J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2020, 27 (12): : 1396 - 1402
[9] Applied relaxation and oral estradiol treatment of vasomotor symptoms in postmenopausal women
Nedstrand, E
Wijma, K
Wyon, Y
Hammar, M
[J]. MATURITAS, 2005, 51 (02) : 154 - 162
[10] A comparison of acupuncture and oral estradiol treatment of vasomotor symptoms in postmenopausal women
Ots, Thomas
[J]. DEUTSCHE ZEITSCHRIFT FUR AKUPUNKTUR, 2007, 50 (03): : 52 - 52

← 1 2 3 4 5 →